Search Results - "Angeletti, C.A."

Relation of neovascularisation to metastasis of non-small-cell lung cancer by Macchiarini, P, Fontanini, G, Hardin, M J, Squartini, F, Angeletti, C A

“…The growth of a tumour beyond a certain size requires angiogenesis. We assessed whether intensity of angiogenesis correlates with metastasis of non-small-cell…”
Get more information

bcl2 and p53 regulate vascular endothelial growth factor (VEGF)-mediated angiogenesis in non-small cell lung carcinoma by Fontanini, G., Boldrini, L., Vignati, S., Chinè, S., Basolo, F., Silvestri, V., Lucchi, M., Mussi, A., Angeletti, C.A., Bevilacqua, G.

“…The aim of this study was to investigate the expression of p53 and bcl2 proteins in a series of 107 non-small cell lung cancers (NSCLC), and to relate such…”
Get full text

Epidermal growth factor receptor (EGFr) expression in non-small cell lung carcinomas correlates with metastatic involvement of hilar and mediastinal lymph nodes in the squamous subtype by Fontanini, G., Vignati, S., Bigini, D., Mussi, A., Lucchi, H., Angeletti, C.A., Pingitore, R., Pepe, S., Basolo, F., Bevilacqua, G.

“…Epidermal growth factor receptor (EGFr) levels were evaluated in paraffin-embedded tumour specimens of nonsmall cell lung cancer (NSCLC) from 176 patients who…”
Get full text

Thymic carcinoma: a report of 13 cases by Lucchi, M, Mussi, A, Ambrogi, M, Gunfiotti, A, Fontanini, G, Basolo, F, Angeletti, C.A

“…Objective: Thymic carcinoma is a rare thymic neoplasm. It is more invasive and has a poorer prognosis than thymoma. We report our experience in the treatment…”
Get full text

Tumor angiogenesis and small cell lung cancer by Chella, A, Lucchi, M, Fontanini, G, Basolo, F, Mussi, A, Angeletti, C.A

Get full text

Paclitaxel/epirubicin/etoposide in patients with extensive-disease small-cell lung cancer (SCLC) by Baldini, E., Chella, A., Del Freo, A., Gragnani, F., Angeletti, C.A., Conte, P.F.

Get full text

Adrenal masses in non-small cell lung carcinoma patients: is there any role for laparoscopic procedures? by Bendinelli, C, Lucchi, M, Buccianti, P, Iacconi, P, Angeletti, C A, Miccoli, P

“…Surgical treatment of adrenal metastases from non-small cell lung carcinoma (NSCLC) is a current and controversial issue. We analyze our experience with the…”
Get more information

0.64 Energy expenditure and gas exchange after thoracic surgery by Brandi, L.S., Bertolini, R., Janni, A., Angeletti, C.A.

Get full text

334 Sequential intensive chemotherapy and high dose chest irradiation in SCLC: A favourable outcome in a long-term follow-up by Chella, A., Ribechini, A., Gragnani, F., Silvano, G., Sainato, A., Marchetti, A., Mussi, A., Angeletti, C.A.

Get full text

456 Evaluation of multiple tumor markers and biological parameters in early-stage NSCLC: A new prognostic tool by Lucchi, M., Mussi, A., Chella, A., Fontanini, G., Ferdeghini, M., Bevilaqua, G., Angeletti, C.A.

Get full text

Phase II study of vinorelbine/ifosfamide/cisplatin for the treatment of advanced non-small-cell lung cancer by Baldini, E., Tibaldi, C., Chella, A., Angletti, C. A., Silvano, G., Andrei, A., Algeri, R., Conte, P. F.

“…Purpose: to evaluate the combination of vinorelbine, ifosfamide and cisplatin (VIP) in patients with advanced nonsmall-cell lung cancer (NSCLC). Patients and…”
Get full text

526 Local immunochemotherapy and systemic chemotherapy in early stage (I–II) malignant pleural mesothelioma by Chella, A., Ribechini, A., Lucchi, M., Menconi, G.F., Melfi, F.M.A., Dini, P., Janni, A., Mussi, A., Angeletti, C.A.

Get full text

690 p53 and K-ras are mutated in different subtypes of bronchioloalveolar carcinoma by Marchetti, A., Buttitta, F., Bertacca, G., Carnicelli, V., Pellegrini, S., Gaeta, P., Filardo, A., Chella, A., Angeletti, C.A., Bevilacqua, G.

Get full text

602 Cyclin D1 and retinoblastoma susceptibility gene alterations in non-small cell lung cancer by Marchetti, Doglioni, C., Barbareschi, M., Buttitta, F., Pellegrini, S., Caffo, O., Gaeta, P., Chella, A., Angeletti, C.A., Dalla Palma, P., Bevilacqua, G.

Get full text

Pre-operative chemotherapy for stage IIIa (N2) non-small cell lung cancer by Chella, A., Lucchi, M., Ribechini, A., Silvano, G., Mussi, A., Janni, A., Angeletti, C.A.

“…From June 1990 to December 1993, 36 patients were enrolled in a phase II study, aimed at determining the feasibility of surgery, patterns of disease recurrence…”
Get full text

Comparison of pulmonary DNA adduct levels, measured by 32P-postlabelling and aryl hydrocarbon hydroxylase activity in lung parenchyma of smokers and ex-smokers by Geneste, O, Camus, A M, Castegnaro, M, Petruzzelli, S, Macchiarini, P, Angeletti, C A, Giuntini, C, Bartsch, H

“…In order to compare pulmonary DNA adducts and aryl hydrocarbon hydroxylase (AHH) activity, we have measured these two parameters in non-neoplastic surgical…”
Get more information

Ga-67 imaging of bronchial metastatic melanoma by Solfanelli, S, Fazzi, P, Frediani, M, Adamo, C, Ricagna, F, Ianni, A, Urbano, M, Angeletti, C A, Giuntini, C

Get more information

Cell-cycle regulators in lung cancer by Marchetti, A., Buttitta, F., Pellegrini, S., Bertacca, G., Doglioni, C., Barbareschi, M., Chella, A., Filardo, A., Tognoni, V., Angeletti, C.A., Dalla Palma, P., Bevilacqua, G.

Get full text